Baillie Gifford WW Health Innovation Fund Class B USD Acc

The fund aims to produce capital growth over the long term by investing mainly in global equities selected from companies involved in the healthcare industry and which are innovative in their focus. The fund will not be restricted to equity securities in the healthcare sector as defined by any particular index.

The fund is exposed to various sectors within the healthcare industry, including biotechnology, health care equipment & supplies, life sciences tools & services, health care technology, pharmaceuticals, and others. Geographically, the fund has exposure to countries such as the United States, Denmark, Netherlands, Germany, Japan, China, and others. The fund is concentrated by the number of stocks held but diversified across a range of healthcare themes.

Investing in the fund carries risks associated with market volatility, movements in the prices of underlying holdings, and the basis on which the fund is priced. Further details on the risks associated with investing in the fund can be found in the Key Investor Information Document (KIID) or the Prospectus. It is important to note that past performance does not predict future returns, and all investment funds have the potential for profit and loss.

https://www.bailliegifford.com/en/uk/intermediaries/literature-library/funds/dublin-funds/factsheets/multicurrency-factsheets/worldwide-health-innovation-fund-class-b-factsheet/